HK1198181A1 - Nmr methods for monitoring blood clot formation nmr - Google Patents
Nmr methods for monitoring blood clot formation nmrInfo
- Publication number
- HK1198181A1 HK1198181A1 HK14111755.6A HK14111755A HK1198181A1 HK 1198181 A1 HK1198181 A1 HK 1198181A1 HK 14111755 A HK14111755 A HK 14111755A HK 1198181 A1 HK1198181 A1 HK 1198181A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- nmr
- blood clot
- clot formation
- monitoring blood
- methods
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/02007—Evaluating blood vessel condition, e.g. elasticity, compliance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/026—Measuring blood flow
- A61B5/0263—Measuring blood flow using NMR
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/10—Location thereof with respect to the patient's body
- A61M60/122—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body
- A61M60/126—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable via, into, inside, in line, branching on, or around a blood vessel
- A61M60/148—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable via, into, inside, in line, branching on, or around a blood vessel in line with a blood vessel using resection or like techniques, e.g. permanent endovascular heart assist devices
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N24/00—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects
- G01N24/08—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects by using nuclear magnetic resonance
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N24/00—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects
- G01N24/08—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects by using nuclear magnetic resonance
- G01N24/088—Assessment or manipulation of a chemical or biochemical reaction, e.g. verification whether a chemical reaction occurred or whether a ligand binds to a receptor in drug screening or assessing reaction kinetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/448—Relaxometry, i.e. quantification of relaxation times or spin density
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7246—Details of waveform analysis using correlation, e.g. template matching or determination of similarity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3303—Using a biosensor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/20—Blood composition characteristics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/20—Blood composition characteristics
- A61M2230/207—Blood composition characteristics hematocrit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/10—Location thereof with respect to the patient's body
- A61M60/104—Extracorporeal pumps, i.e. the blood being pumped outside the patient's body
- A61M60/117—Extracorporeal pumps, i.e. the blood being pumped outside the patient's body for assisting the heart, e.g. transcutaneous or external ventricular assist devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/10—Location thereof with respect to the patient's body
- A61M60/122—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/10—Location thereof with respect to the patient's body
- A61M60/122—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body
- A61M60/165—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable in, on, or around the heart
- A61M60/178—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable in, on, or around the heart drawing blood from a ventricle and returning the blood to the arterial system via a cannula external to the ventricle, e.g. left or right ventricular assist devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/20—Type thereof
- A61M60/205—Non-positive displacement blood pumps
- A61M60/216—Non-positive displacement blood pumps including a rotating member acting on the blood, e.g. impeller
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/50—Details relating to control
- A61M60/508—Electronic control means, e.g. for feedback regulation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/22—Haematology
- G01N2800/226—Thrombotic disorders, i.e. thrombo-embolism irrespective of location/organ involved, e.g. renal vein thrombosis, venous thrombosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pathology (AREA)
- Chemical & Material Sciences (AREA)
- High Energy & Nuclear Physics (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- General Physics & Mathematics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Vascular Medicine (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- Medical Informatics (AREA)
- Physiology (AREA)
- Surgery (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Mechanical Engineering (AREA)
- Anesthesiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161507307P | 2011-07-13 | 2011-07-13 | |
US201161537396P | 2011-09-21 | 2011-09-21 | |
US201161538257P | 2011-09-23 | 2011-09-23 | |
US201161560920P | 2011-11-17 | 2011-11-17 | |
US201261596445P | 2012-02-08 | 2012-02-08 | |
US201261625945P | 2012-04-18 | 2012-04-18 | |
PCT/US2012/046669 WO2013010080A1 (en) | 2011-07-13 | 2012-07-13 | Nmr methods for monitoring blood clot formation |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1198181A1 true HK1198181A1 (en) | 2015-03-13 |
Family
ID=47506571
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK14111755.6A HK1198181A1 (en) | 2011-07-13 | 2014-11-21 | Nmr methods for monitoring blood clot formation nmr |
Country Status (8)
Country | Link |
---|---|
US (3) | US9599627B2 (ja) |
EP (2) | EP3321373B1 (ja) |
JP (3) | JP6122848B2 (ja) |
CN (1) | CN103917658B (ja) |
AU (1) | AU2012281017B2 (ja) |
CA (1) | CA2841484A1 (ja) |
HK (1) | HK1198181A1 (ja) |
WO (1) | WO2013010080A1 (ja) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2009308841B2 (en) | 2008-10-29 | 2014-07-17 | T2 Biosystems, Inc. | NMR detection of coagulation time |
US9599627B2 (en) | 2011-07-13 | 2017-03-21 | T2 Biosystems, Inc. | NMR methods for monitoring blood clot formation |
US10620205B2 (en) | 2011-09-21 | 2020-04-14 | T2 Biosystems, Inc. | NMR methods for endotoxin analysis |
CA2893591A1 (en) | 2012-12-07 | 2014-06-12 | T2 Biosystems, Inc. | Methods for monitoring tight clot formation |
US10156567B2 (en) * | 2012-12-17 | 2018-12-18 | General Electric Company | In-vitro magnetic resonance detection of a target substance without separating bound magnetic nanoparticles from unbound magnetic nanoparticles |
WO2014185195A1 (ja) * | 2013-05-14 | 2014-11-20 | 大陽工業株式会社 | 血液凝固の検査方法および装置 |
US10488480B2 (en) | 2014-02-11 | 2019-11-26 | The General Hospital Corporation | System and method for adaptive dictionary matching in magnetic resonance fingerprinting |
WO2015168015A1 (en) * | 2014-04-28 | 2015-11-05 | T2 Biosystems, Inc. | Systems and methods for identifying coagulopathies |
US11300531B2 (en) | 2014-06-25 | 2022-04-12 | Aspect Ai Ltd. | Accurate water cut measurement |
US10422845B2 (en) | 2014-10-24 | 2019-09-24 | The General Hospital Corporation | Systems and methods for steady-state magnetic resonance fingerprinting |
FR3029286B1 (fr) * | 2014-11-27 | 2017-11-24 | Total Raffinage Chimie | Methode de suivi d'un procede de raffinage d'une charge d'hydrocarbures. |
WO2016109554A1 (en) * | 2014-12-29 | 2016-07-07 | Bridgestone Corporation | Methods for quantifying rubber content in a plant with nmr |
WO2016127144A1 (en) * | 2015-02-06 | 2016-08-11 | University Of North Texas Health Science Center At Fort Worth | Methods and tools for diagnosing insulin resistance and assessing health status usng nmr relaxation times for water |
FR3033645B1 (fr) * | 2015-03-12 | 2018-10-12 | Institut National De Recherche En Sciences Et Technologies Pour L'environnement Et L'agriculture (Irstea) | Procede d'identification et de quantification des proportions relatives des differentes fractions cristallisees presentes dans un coulis d'hydrate et son utilisation pour les fluides frigoporteurs |
IL238034B (en) * | 2015-03-30 | 2018-05-31 | Shmri Haim Ltd | System and manual tracker for real-time non-invasive tissue analysis |
EP3314259A4 (en) * | 2015-06-26 | 2019-08-07 | T2 Biosystems, Inc. | SYSTEMS AND METHODS FOR PANELS OF MULTIPLE HEMOSTASE TEST SAMPLES |
CA2956297C (en) | 2016-01-26 | 2024-02-13 | Perm Instruments Inc. | Composite fid-cpmg process for fast relaxing media determination |
CN106198599B (zh) * | 2016-08-22 | 2018-04-03 | 上海交通大学 | 检测阿尔茨海默病相关代谢小分子的核磁共振模型及构建 |
DE102016224691A1 (de) * | 2016-12-12 | 2018-06-14 | Numares Ag | Verfahren zur Analyse eines NMR-Spektrums einer lipoproteinhaltigen Probe |
CN108344875B (zh) * | 2017-01-22 | 2021-11-02 | 上海长岛生物技术有限公司 | 提高活化部分凝血活酶时间试剂对肝素敏感性的方法及用途 |
US10345251B2 (en) | 2017-02-23 | 2019-07-09 | Aspect Imaging Ltd. | Portable NMR device for detecting an oil concentration in water |
CN106885895B (zh) * | 2017-02-27 | 2019-04-05 | 常熟常江生物技术有限公司 | 血小板功能检测方法 |
WO2018163188A1 (en) | 2017-03-09 | 2018-09-13 | B.G. Negev Technologies And Applications Ltd., At Ben-Gurion University | Generation of nuclear magnetic resonance multidimensional t1(spin-matrix)-t2(spin-spin) energy relaxation maps and uses thereof |
EP3483619A1 (en) * | 2017-11-13 | 2019-05-15 | Technische Universität München | Automated noninvasive determining the sex of an embryo of and the fertility of a bird's egg |
US11585770B2 (en) * | 2018-10-04 | 2023-02-21 | University Of Maryland, Baltimore | In situ determination of alum filling evenness and sedimentation in pharmaceutical products using water proton NMR |
US11543371B2 (en) | 2018-10-04 | 2023-01-03 | University Of Maryland, Baltimore | In situ, real-time in-line detection of filling errors in pharmaceutical product manufacturing using water proton NMR |
CN109740819A (zh) * | 2019-01-11 | 2019-05-10 | 中国环境监测总站 | 一种水环境监测算法 |
US11568020B1 (en) * | 2019-02-06 | 2023-01-31 | SNO, Inc. | System and methods for network sensitivity analysis |
CN111044551A (zh) * | 2019-12-27 | 2020-04-21 | 大连工业大学 | 一种基于低场核磁共振判断中国蛤蜊蛋白变性的方法 |
WO2021226098A1 (en) * | 2020-05-04 | 2021-11-11 | Amphastar Pharmaceuticals Inc. | Nmr methods for characterizing iron sucrose |
RU2760095C1 (ru) * | 2021-05-26 | 2021-11-22 | Александр Геннадьевич Старовойтов | Способ количественной оценки агрегационной активности тромбоцитов у пациентов с новой коронавирусной инфекцией |
CN113723775B (zh) * | 2021-08-16 | 2023-09-12 | 国网上海市电力公司 | 一种基于电力大数据的企业及行业运营风险的评估方法 |
CN113536606A (zh) * | 2021-09-15 | 2021-10-22 | 成都同飞科技有限责任公司 | 一种水体水质变化检测方法及系统、存储介质和装置 |
CN115081207B (zh) * | 2022-06-17 | 2023-03-10 | 上海玫克生储能科技有限公司 | 锂电池的静置弛豫仿真方法、系统、终端设备及存储介质 |
WO2024196843A1 (en) * | 2023-03-17 | 2024-09-26 | Texas Tech University System | Method and device for detecting subclinical hypoxemia using whole blood t2p |
CN117233364B (zh) * | 2023-11-16 | 2024-02-02 | 苏州思迈德生物科技有限公司 | 一种血栓弹力图的参数提取方法 |
Family Cites Families (100)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5140981A (en) * | 1974-10-02 | 1976-04-06 | Hokkaido Daiga Kuchyo | Ookuno kanwajikanno bunrishikibetsuho |
JPS5913521B2 (ja) | 1975-06-19 | 1984-03-30 | メイトウサンギヨウ カブシキガイシヤ | 磁性酸化鉄・デキストラン複合体の製造法 |
FI58868C (fi) * | 1979-06-01 | 1981-05-11 | Instrumentarium Oy | Nmr-diagnosanordning |
US4374360A (en) | 1980-05-29 | 1983-02-15 | Sepponen Raimo E | NMR Diagnosis apparatus |
US4452773A (en) | 1982-04-05 | 1984-06-05 | Canadian Patents And Development Limited | Magnetic iron-dextran microspheres |
US4920061A (en) | 1984-03-02 | 1990-04-24 | The University Of Texas System | Biological magnetic colloids |
US5262176A (en) | 1986-07-03 | 1993-11-16 | Advanced Magnetics, Inc. | Synthesis of polysaccharide covered superparamagnetic oxide colloids |
US4875486A (en) | 1986-09-04 | 1989-10-24 | Advanced Techtronics, Inc. | Instrument and method for non-invasive in vivo testing for body fluid constituents |
US5136095A (en) | 1987-05-19 | 1992-08-04 | Syntex (U.S.A.) Inc. | Reversible agglutination mediators |
US5042488A (en) * | 1987-09-29 | 1991-08-27 | The Washington University | Methods employing deuterium for obtaining direct, observable deuterium magnetic resonance images in vivo and in situ |
US4837163A (en) * | 1987-10-02 | 1989-06-06 | Tsuyoshi Ohnishi | Simple blood test for diagnosing malignant hyperthermia |
WO1990006045A2 (en) | 1988-11-21 | 1990-06-14 | Dynal As | Nucleic acid probes |
US5049819A (en) | 1989-06-30 | 1991-09-17 | Auburn International, Inc. | Magnetic resonance analysis in real time, industrial usage mode |
JP2726520B2 (ja) | 1989-10-20 | 1998-03-11 | 名糖産業株式会社 | 有機磁性複合体 |
US5254460A (en) | 1990-05-03 | 1993-10-19 | Advanced Magnetics, Inc. | Solvent mediated relaxation assay system |
US5164297A (en) | 1990-05-03 | 1992-11-17 | Advanced Magnetics Inc. | Solvent mediated relaxation assay system |
IL98744A0 (en) | 1990-07-06 | 1992-07-15 | Gen Hospital Corp | Method of studying biological tissue using monocrystalline particles |
DE10199064I2 (de) | 1991-06-11 | 2004-07-12 | Meito Sangyo Kk | Oxidierte Zusammensetzung, enthaltend ein wasserlösliches Carboxypolysaccharid und magnetisches Eisenoxid. |
US5445971A (en) | 1992-03-20 | 1995-08-29 | Abbott Laboratories | Magnetically assisted binding assays using magnetically labeled binding members |
US5445970A (en) | 1992-03-20 | 1995-08-29 | Abbott Laboratories | Magnetically assisted binding assays using magnetically labeled binding members |
US5637469A (en) | 1992-05-01 | 1997-06-10 | Trustees Of The University Of Pennsylvania | Methods and apparatus for the detection of an analyte utilizing mesoscale flow systems |
JP3362192B2 (ja) | 1994-12-06 | 2003-01-07 | 味の素株式会社 | 検査方法及び検査薬 |
US6500343B2 (en) | 1995-02-21 | 2002-12-31 | Iqbal W. Siddiqi | Method for mixing and separation employing magnetic particles |
US6884357B2 (en) | 1995-02-21 | 2005-04-26 | Iqbal Waheed Siddiqi | Apparatus and method for processing magnetic particles |
US6297062B1 (en) | 1996-03-07 | 2001-10-02 | Bio-Magnetics Ltd. | Separation by magnetic particles |
JP2000510582A (ja) | 1996-04-25 | 2000-08-15 | ゼニコン・サイエンシーズ・コーポレーション | 微粒子標識を使用した分析物アッセイ |
AU3374597A (en) | 1996-06-07 | 1998-01-05 | Immunivest Corporation | Magnetic separation employing external and internal gradients |
EP0918885B1 (en) | 1996-07-29 | 2007-04-11 | Nanosphere LLC | Nanoparticles having oligonucleotides attached thereto and uses therefor |
US6361944B1 (en) | 1996-07-29 | 2002-03-26 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
WO1998008899A1 (fr) | 1996-08-30 | 1998-03-05 | Meito Sangyo Kabushiki Kaisha | Composite contenant un derive de polysaccharide et un oxyde metallique magnetique |
ATE253943T1 (de) | 1996-09-12 | 2003-11-15 | Amersham Health As | Markerzusammensetzungen |
JP3876022B2 (ja) | 1996-09-26 | 2007-01-31 | 生化学工業株式会社 | 血液凝固時間に影響を与える物質の定量方法 |
FR2758884B1 (fr) | 1997-01-30 | 1999-04-02 | Bio Merieux | Procede pour isoler, notamment detecter ou quantifier un analyte dans un milieu |
JP3917239B2 (ja) | 1997-06-05 | 2007-05-23 | 生化学工業株式会社 | 血液凝固時間の測定方法 |
DE19822123C2 (de) | 1997-11-21 | 2003-02-06 | Meinhard Knoll | Verfahren und Vorrichtung zum Nachweis von Analyten |
US6346813B1 (en) * | 1998-08-13 | 2002-02-12 | Schlumberger Technology Corporation | Magnetic resonance method for characterizing fluid samples withdrawn from subsurface formations |
JP2000166897A (ja) | 1998-12-11 | 2000-06-20 | Toshiba Corp | Mri装置およびmrイメージング方法 |
US6719973B1 (en) | 1998-12-24 | 2004-04-13 | National University Of Singapore | Recombinant proteins and peptides for endotoxin biosensors, endotoxin removal, and anti-microbial and anti-endotoxin therapeutics |
US7179652B2 (en) * | 1999-02-22 | 2007-02-20 | Haemoscope Corporation | Protocol for monitoring platelet inhibition |
DE60043188D1 (de) | 1999-04-09 | 2009-12-03 | Amag Pharmaceuticals Inc | Hitzebeständige umhüllte kolloidale eisenoxide |
DE60045739D1 (de) | 1999-06-25 | 2011-04-28 | Nanosphere Inc | Nanopartikel mit gebundenen oligonukleotiden und deren verwendungen |
JP2003528289A (ja) | 1999-08-06 | 2003-09-24 | インスティテュート・フュア・ディアグノスティクフォルシュンク・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング・アン・デア・フライエン・ウニヴエアズィテート・ベルリン | 磁性粒子の二重屈折の緩和の測定を利用する結合反応を検出するための方法 |
EP1216060A2 (de) | 1999-09-14 | 2002-06-26 | Biomedical Apherese Systeme GmbH | Magnetische nanoteilchen mit biochemischer wirksamkeit und verfahren zu ihrer herstellung sowie ihre verwendung |
US6294342B1 (en) | 1999-09-29 | 2001-09-25 | Abbott Laboratories | Magnetically assisted binding assays utilizing a magnetically responsive reagent |
US6307372B1 (en) | 1999-11-02 | 2001-10-23 | Glaxo Wellcome, Inc. | Methods for high throughput chemical screening using magnetic resonance imaging |
FR2800635B1 (fr) | 1999-11-05 | 2002-07-26 | Bio Merieux | Nanospheres composites, conjugues derives, procede de preparation et leurs utilisations |
US6254830B1 (en) | 1999-11-05 | 2001-07-03 | The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations | Magnetic focusing immunosensor for the detection of pathogens |
DE10046514A1 (de) * | 2000-09-15 | 2002-04-25 | Diagnostikforschung Inst | Verfahren zur bildlichen Darstellung und Diagnose von Thromben mittels Kernspintomographie unter Verwendung partikulärer Kontrastmittel |
US6940378B2 (en) | 2001-01-19 | 2005-09-06 | Halliburton Energy Services | Apparatus and method for magnetic resonance measurements in an interior volume |
WO2002086500A2 (en) | 2001-04-23 | 2002-10-31 | Metabometrix Limited | Methods for analysis of spectral data and their applications: atherosclerosis/coronary heart disease |
FR2824563B1 (fr) | 2001-05-10 | 2004-12-03 | Bio Merieux | Particules composites, conjugues derives, procede de preparation et applications |
WO2002098364A2 (en) | 2001-06-06 | 2002-12-12 | The General Hospital Corporation | Magnetic-nanoparticle conjugates and methods of use |
BRPI0210681B8 (pt) | 2001-06-28 | 2021-07-27 | Biowhittaker Inc | métodos e reagentes para detectar endotoxina |
FR2832507B1 (fr) | 2001-11-20 | 2004-02-20 | Stago Diagnostica | Methode de detection d'analyte(s) a l'aide de particules magnetiques colloidales |
US7018849B2 (en) | 2002-01-15 | 2006-03-28 | Piasio Roger N | Process for (A) separating biological/ligands from dilute solutions and (B) conducting an immunochromatographic assay thereof employing superparamagnetic particles throughtout |
CN100350252C (zh) * | 2002-05-01 | 2007-11-21 | 瑟纳普斯有限责任公司 | 实时测定凝血酶活性的方法及实施该方法的试剂盒 |
CA2418229A1 (en) | 2002-05-16 | 2003-11-16 | Rohan Dharmakumar | Microbubble construct for sensitivity enhanced mr manometry |
US6798200B2 (en) | 2002-06-03 | 2004-09-28 | Long-Sheng Fan | Batch-fabricated gradient and RF coils for submicrometer resolution magnetic resonance imaging and manipulation |
US7217542B2 (en) | 2002-10-31 | 2007-05-15 | Hewlett-Packard Development Company, L.P. | Microfluidic system for analyzing nucleic acids |
US20080305048A1 (en) | 2003-12-10 | 2008-12-11 | The General Hospital Corporation | Self-Assembling Nanoparticle Conjugates |
EP1735668A2 (en) | 2004-04-13 | 2006-12-27 | President And Fellows Of Harvard College | Methods and apparatus for manipulation and/or detection of biological samples and other objects |
EP1751534A1 (en) | 2004-05-18 | 2007-02-14 | Koninklijke Philips Electronics N.V. | Magnetic rotation to improve signal-over-background in biosensing |
DE102004059055A1 (de) | 2004-12-07 | 2006-06-08 | Dade Behring Marburg Gmbh | Verfahren zur automatischen Bestimmung des endogenen Thrombinpotenzials |
US7781228B2 (en) | 2005-04-07 | 2010-08-24 | Menon & Associates, Inc. | Magnetic resonance system and method to detect and confirm analytes |
ATE515711T1 (de) | 2005-05-09 | 2011-07-15 | Gen Hospital Corp | Sensoren auf wasserrelaxationsbasis |
EP1896103A4 (en) | 2005-05-27 | 2009-12-09 | Univ Texas | DETECTION OF CELLS AND COMPOSITIONS BY OPTICAL COHERENCE TOMOGRAPHY |
EP1932009B1 (en) | 2005-08-31 | 2014-02-12 | T2 Biosystems, Inc. | Nmr device for detection of analytes involving magnetic particles |
FR2894970B1 (fr) | 2005-12-15 | 2008-01-25 | Biomerieux Sa | Procede de preparation de particules composites, particules composites obtenues et leur utilisation dans un test diagnostic |
US7274191B2 (en) | 2005-12-29 | 2007-09-25 | Intel Corporation | Integrated on-chip NMR and ESR device and method for making and using the same |
US8277837B2 (en) * | 2006-01-11 | 2012-10-02 | Entegrion, Inc. | Hemostatic textile |
US20070166730A1 (en) | 2006-01-19 | 2007-07-19 | Menon & Associates, Inc. | Magnetic resonance system and method to detect and confirm analytes |
US20080261261A1 (en) | 2006-03-31 | 2008-10-23 | Kmg2 Sensors Corporation | System/unit and method employing a plurality of magnetoelastic sensor elements for automatically quantifying parameters of whole blood and platelet-rich plasma |
WO2008007270A2 (en) | 2006-06-21 | 2008-01-17 | Spinomix S.A. | A method for manipulating magnetic particles in a liquid medium |
US8339135B2 (en) | 2006-08-21 | 2012-12-25 | Stc.Unm | Biological detector and method |
TWI322793B (en) | 2006-10-02 | 2010-04-01 | Chung Cheng Inst Of Technology Nat Defense University | Functionalized magnetizable microspheres and preparation thereof |
AU2007317787B2 (en) | 2006-11-08 | 2012-07-12 | T2 Biosystems, Inc. | NMR systems for in vivo detection of analytes |
CN104764724A (zh) | 2006-12-12 | 2015-07-08 | 皇家飞利浦电子股份有限公司 | 用于检测标记颗粒的微电子传感器装置 |
WO2008127497A2 (en) | 2007-02-21 | 2008-10-23 | The Regents Of The University Of California | Hemostatic compositions and methods of use |
JP2008209350A (ja) | 2007-02-28 | 2008-09-11 | Matsushita Electric Ind Co Ltd | 血液凝固時間測定装置 |
WO2008119054A1 (en) | 2007-03-27 | 2008-10-02 | Abqmr, Inc. | System and method for detecting labeled entities using microcoil magnetic mri |
US8067938B2 (en) | 2007-05-03 | 2011-11-29 | Abqmr, Inc. | Microcoil NMR detectors |
US20110020785A1 (en) | 2007-07-26 | 2011-01-27 | T2 Biosystems, Inc. | Diagnostic Information Generation and Use |
WO2009026251A1 (en) | 2007-08-17 | 2009-02-26 | The General Hospital Corporation | Detecting ions and measuring ion concentrations |
US8421458B2 (en) | 2007-09-28 | 2013-04-16 | T2 Biosystems, Inc. | NMR diagnostics by means of a plastic sample container |
EP2207537B1 (en) * | 2007-10-02 | 2017-06-14 | Fremont Group Ltd | Systemic pro-hemostatic effect of sympathicomimetics with agonistic effects on alpha-adrenergic and/or beta-adrenergic receptors of the sympathetic nervous system, related to improved clot strength |
US20110091987A1 (en) | 2007-10-04 | 2011-04-21 | Ralph Weissleder | Miniaturized Magnetic Resonance Systems and Methods |
US8143896B2 (en) | 2007-10-23 | 2012-03-27 | Abqmr, Inc. | Microcoil magnetic resonance detectors |
WO2009061481A1 (en) * | 2007-11-06 | 2009-05-14 | T2 Biosystems, Inc. | Small magnet and rf coil for magnetic resonance relaxometry |
WO2009063840A1 (ja) | 2007-11-12 | 2009-05-22 | Hiroshima University | エンドトキシンの濃度測定方法および濃度測定用キット |
US20120223705A1 (en) * | 2007-12-21 | 2012-09-06 | T2 Biosystems, Inc. | Magnetic resonance system with implantable components and methods of use thereof |
US20110275985A1 (en) | 2008-07-03 | 2011-11-10 | T2 Biosystems, Inc. | Magnetic nanosensor compositions and bioanalytical assays therefor |
CA2638697C (en) | 2008-08-15 | 2014-11-18 | Schlumberger Canada Limited | Methods for determining in situ the viscosity of heavy oil using nuclear magnetic resonance relaxation time measurements |
AU2009308841B2 (en) | 2008-10-29 | 2014-07-17 | T2 Biosystems, Inc. | NMR detection of coagulation time |
JP2011038945A (ja) * | 2009-08-14 | 2011-02-24 | Bridgestone Corp | ゴム材料の非破壊検査方法 |
US8563298B2 (en) | 2010-10-22 | 2013-10-22 | T2 Biosystems, Inc. | NMR systems and methods for the rapid detection of analytes |
EP3974831A1 (en) | 2010-10-22 | 2022-03-30 | T2 Biosystems, Inc. | Methods for detecting the presence of a bacterium in a whole blood sample |
US9599627B2 (en) | 2011-07-13 | 2017-03-21 | T2 Biosystems, Inc. | NMR methods for monitoring blood clot formation |
US10620205B2 (en) | 2011-09-21 | 2020-04-14 | T2 Biosystems, Inc. | NMR methods for endotoxin analysis |
EP2677037B1 (en) | 2012-06-21 | 2016-04-13 | Synapse B.V. | Simultaneous measurement of thrombin generation and clot strength in plasma and whole blood |
EP2864821A1 (en) | 2012-06-25 | 2015-04-29 | T2 Biosystems, Inc. | Portable device for nmr based analysis of rheological changes in liquid samples |
-
2012
- 2012-07-13 US US14/131,898 patent/US9599627B2/en active Active
- 2012-07-13 AU AU2012281017A patent/AU2012281017B2/en active Active
- 2012-07-13 CN CN201280044411.XA patent/CN103917658B/zh active Active
- 2012-07-13 WO PCT/US2012/046669 patent/WO2013010080A1/en active Application Filing
- 2012-07-13 EP EP17001484.9A patent/EP3321373B1/en active Active
- 2012-07-13 CA CA2841484A patent/CA2841484A1/en not_active Abandoned
- 2012-07-13 JP JP2014520367A patent/JP6122848B2/ja active Active
- 2012-07-13 EP EP12812054.0A patent/EP2732046B1/en active Active
-
2014
- 2014-11-21 HK HK14111755.6A patent/HK1198181A1/xx unknown
-
2015
- 2015-07-20 US US14/803,577 patent/US9797914B2/en active Active
-
2016
- 2016-10-19 JP JP2016204833A patent/JP6386510B2/ja active Active
-
2017
- 2017-09-27 US US15/717,113 patent/US10697984B2/en active Active
-
2018
- 2018-08-09 JP JP2018149867A patent/JP2019039914A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2019039914A (ja) | 2019-03-14 |
JP6386510B2 (ja) | 2018-09-05 |
US20140212901A1 (en) | 2014-07-31 |
CN103917658B (zh) | 2016-09-21 |
EP2732046B1 (en) | 2017-09-06 |
CA2841484A1 (en) | 2013-01-17 |
EP2732046A1 (en) | 2014-05-21 |
JP2017062239A (ja) | 2017-03-30 |
EP2732046A4 (en) | 2015-03-25 |
EP3321373A1 (en) | 2018-05-16 |
US10697984B2 (en) | 2020-06-30 |
JP6122848B2 (ja) | 2017-04-26 |
US20160018421A1 (en) | 2016-01-21 |
WO2013010080A1 (en) | 2013-01-17 |
CN103917658A (zh) | 2014-07-09 |
US9797914B2 (en) | 2017-10-24 |
AU2012281017A1 (en) | 2014-01-30 |
JP2014521091A (ja) | 2014-08-25 |
US20180113141A1 (en) | 2018-04-26 |
US9599627B2 (en) | 2017-03-21 |
EP3321373B1 (en) | 2020-01-15 |
AU2012281017B2 (en) | 2017-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1198181A1 (en) | Nmr methods for monitoring blood clot formation nmr | |
EP3425063C0 (en) | PROCEDURE FOR DETECTING ANALYTES | |
RS60728B1 (sr) | Postupak za upravljanje donacijama krvi | |
GB2491983B (en) | Vibration monitoring | |
EP2753236A4 (en) | METHOD FOR DETECTING R-WAVES | |
EP2906697A4 (en) | METHODS OF MONITORING C9ORF72 EXPRESSION | |
GB201101858D0 (en) | Health monitoring | |
EP2778698A4 (en) | BATTERY CONDITION MONITORING SYSTEM | |
GB201411337D0 (en) | Seismic monitoring | |
PL2485026T3 (pl) | System monitorowania stanu technicznego struktury | |
IL232176B (en) | Magnetic resonance maps for tissue examination | |
EP2637017A4 (en) | METHOD FOR MEASURING FILLING CAPACITY | |
EP2929047A4 (en) | METHOD FOR MONITORING THE FORMING OF SEALED GERINNSELN | |
EP2788755A4 (en) | ARRANGEMENT FOR HEMOLYSIS DETECTION | |
HK1212443A1 (en) | Method for evaluating blood coagulation reaction | |
GB2496402B (en) | Monitoring apparatus | |
EP2762076A4 (en) | ANALYTÜBERWACHUNGSSYSTEM | |
SG10201602761TA (en) | Methods For Detecting Contaminants Of Glucose Polymers | |
IL227295A0 (en) | diagnostic method | |
GB201000532D0 (en) | Method for monitoring of blood components | |
AP2013007084A0 (en) | Diagnostic method | |
HK1190593A1 (en) | Measuring device for measuring cerebral parameters | |
EP2695114A4 (en) | INSTRUMENTATION SYSTEM FOR DETERMINING RISK FACTORS | |
EP2661625A4 (en) | DIAGNOSTIC PROCEDURE | |
PL2691015T3 (pl) | System monitorowania |